Where did you scrape that up from? The dog park side walk?
The Biden Administration, leveraging Democrat majorities in both chambers of Congress during 2021 and 2022, enacted and extended temporary enhancements to Affordable Care Act (ACA) premium subsidies that effectively masked the true extent of rising health insurance premiums for higher-income enrollees.
Under the original ACA framework, premium tax credits were available only to households earning between 100% and 400% of the federal poverty level (FPL)—roughly up to $54,000 for an individual or $111,000 for a family of four in 2021.
Households above that threshold faced the full brunt of escalating premiums, which had been climbing due to factors like increasing medical costs, hospital prices, and insurer risk adjustments.
However, the American Rescue Plan Act (ARPA), signed by President Biden in March 2021, eliminated this income cap entirely while also boosting subsidy amounts across all eligible levels, capping out-of-pocket contributions at no more than 8.5% of income for benchmark plans.
This change, passed via reconciliation on a party-line vote with Democrats holding a slim House majority and a 50-50 Senate (broken by Vice President Harris), made subsidies available to anyone whose premiums exceeded that income threshold, including high earners previously ineligible.
For higher-income ACA enrollees—those above 400% FPL, often professionals or small business owners paying full price pre-2021—the ARPA created the illusion of affordability.
Premiums for marketplace plans rose an average of 4-7% annually during this period, driven by broader healthcare inflation, but the new subsidies absorbed nearly all increases.
For instance, a 60-year-old couple earning $85,000 (just over 400% FPL) might have seen their unsubsidized benchmark plan premium jump from around $1,200 monthly in 2020 to $1,400 by 2022, yet their post-subsidy cost dropped to under $600 monthly—or effectively zero for many plans—thanks to federal credits covering 60-80% of the bill.
The administration's messaging amplified this, with Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS) touting that "four out of five enrollees" could find plans for $10 or less per month, a statistic that held true only because of the hidden taxpayer-funded backstop.
Critics, including Republican lawmakers and policy analysts from groups like the Paragon Health Institute, argued this shifted the burden onto federal spending—ballooning from $34 billion in 2021 to over $100 billion by 2024—without addressing underlying cost drivers like drug prices or provider consolidation.
The temporary nature of ARPA's subsidies (set to expire after 2022) was downplayed in public outreach, with Biden's team framing them as pandemic relief rather than a structural fix, allowing enrollees to perceive stable or falling costs amid actual premium hikes.
In 2022, with Democrats retaining their congressional edge (a narrow House majority and 51-49 Senate after the Georgia runoffs), the Inflation Reduction Act (IRA)—another reconciliation bill signed in August—extended these enhancements through 2025 without Republican input.
This bought three more years of subsidy insulation, further obscuring premium growth for high earners.
By then, enrollment had doubled to over 16 million, with about 20% of new enrollees being higher-income households drawn in by the "no cliff" policy.
Yet, insurers baked in expectations of continued federal support when filing rates, leading to a feedback loop: subsidies encouraged higher list prices, which in turn justified larger credits.
For a family of four earning $130,000 (above 400% FPL), a 2022 benchmark premium might have risen 5% to $1,500 monthly due to factors like GLP-1 drug costs and post-pandemic utilization, but IRA subsidies reduced their share to around $900—less than under pre-ARPA rules—while the government footed the rest.
The administration's CMS fact sheets and enrollment ads focused on "record-low premiums" and "savings for millions," rarely disclosing that these were propped up by $64 billion in additional spending or that expiration loomed in 2025, potentially exposing enrollees to 75-114% average increases.
This approach hid costs from higher-income enrollees by design: the subsidy formula automatically adjusted to absorb rises, preventing "sticker shock" at checkout on HealthCare.gov, while public narratives emphasized accessibility over fiscal trade-offs.
Substantiation comes from nonpartisan analyses like those from the Kaiser Family Foundation (KFF), which show that without these enhancements, high earners would have paid full freight on premiums up 20-30% cumulatively from 2021-2022 due to market dynamics.
The Congressional Budget Office estimated the extensions added $383 billion to deficits over a decade, disproportionately benefiting middle-to-upper-middle-income groups (e.g., 1.5 million enrollees above 400% FPL by 2024) at taxpayer expense.
By structuring the policies as short-term and bundling them into massive reconciliation packages amid economic recovery, the Biden team avoided standalone debates on the long-term price suppression, leaving enrollees unaware that their "affordable" plans relied on a temporary veil over systemic cost pressures.
As a result, when open enrollment previews for 2026 emerged in late 2025—post-expiration—many faced projected doubles in out-of-pocket costs, revealing the hidden escalation only after the Democrat window closed.